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Abstract  
Sleep plays an important role in maintaining brain function, memory consolidation, 
hormonal balance, immune system function, growth, and repair. The physiological and 
psychological effects of disruptions in sleep highlight its importance in human health and 
wellness. Epigenetic roles are proposed in sleep, and circadian regulation, but only a limited 
number of studies have determined the mechanism that underlies the epigenetics of 
environmental factors interacting with the sleep, particularly the ones related to sleep 
disruption. Therefore, studying epigenetics of sleep and sleep disorders can help elucidate 
the way these factors promote or inhibit sleep disorders, potentially guiding the 
development of precision medicines or preventive strategies. However, before discovering 
useful epigenetic-based interventions for sleep disorders, we need to overcome many 
challenges. As a relatively new field, there are unmet needs that call for further investigation 
of epigenetic mechanisms underlying sleep disruption. This review focuses on the current 
status of epigenetic mechanisms in sleep disruption (e.g., sleep deprivation and circadian 
dysregulation), which highlights a great potential of both animal and human studies to 
explain the disturbances in sleep, associated consequences, and novel therapeutic 
potentials. Translating the epigenetic research in sleep disturbances can eventually lead to 
better diagnosis, prognosis, prevention, and therapy in the clinics.  
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1. Sleep 
Sleep is regulated by homeostatic and circadian mechanisms and is a reversible state. During 
sleep, a low sensory response with motor immobility is observed throughout the animal kingdom, 
with only a few exemptions [1]. It is defined as a fundamental element of life, with many studies 
collectively demonstrating its essential role in health. Several theories are merged to explain the 
function of sleep in decreasing the energy demands [2], restoring cellular processes [3], 
maintaining immune health [4], and regulating the communication between neurons [5]. 
Neuronal-based studies have highlighted the significant role of sleep in memory consolidation [6]. 
Achieving good sleep quality (e.g., low sleep latency, low number of awakenings, low waking after 
sleep onset, and better sleep efficiency) [7] and duration [8, 9] is necessary for overall health and 
well-being. Poor sleep is linked to a diverse range of health issues, including developmental 
impairments, somatic and cognitive deficits, and rapid aging. Sleep plays a multidimensional role 
in one’s physiological and psychosocial aspects of life and is affected by a diverse range of internal 
and external parameters. Cellular mechanisms underlying the sleep function are being elucidated 
gradually. In humans, sleep diversity exists between the individuals and also within an individual in 
their life span, which proposes the role of genetic variations among individuals. However, 
environmental and lifestyle factors also contribute to this diversity.  
Sleep in mammals consists of cycles of rapid eye movement (REM) and different stages of non-
REM (NREM), which reflect the cortical activity patterns and can be monitored by 
electroencephalography (EEG). During sleep, a coordinated neural activity is seen in the 
hippocampus [10], where certain patterns of interactions are observed between CA1 pyramidal 
neurons and inhibitory interneurons [11]. It is proposed that the coordination between 
hippocampal and extra-hippocampal oscillatory activity during sleep promotes memory 
consolidation that is formed during wakefulness [12]. Sleep-wake cycles are regulated by the 
circadian clock, which is the master pacemaker in the suprachiasmatic nucleus that coordinates 
complex physiological processes and behaviors with the circadian rhythmicity [13]. Circadian 
rhythm is derived from the 24 h day and night (light-dark) cycle that accompanies biological cycles, 
including fasting-feeding, body temperature, hormone secretion, and sleep-wake. Also, both the 
internal feedback loop and the external environment interact with the circadian rhythms. Several 
chronotypes (preferred time of day for daily activities) exist while the two extreme preferences 
are termed as morningness and eveningness [14, 15], and these two chronotypes are reported to 
have genetic components [16, 17], i.e., they express two circadian clock-regulated genes Per3 and 
Nr1d2. Ingram et al. in 2016 [16] measured the expression of Per3 and Nr1d2 in hair follicle 
samples and assigned the RNA chronotypes- morningness and eveningness to the participants. A 
difference was identified between these two groups even in decision-making tasks, where only a 
3-hour phase difference in molecular clockwork was sufficient to influence the decision-making, 
highlighting the effects of endogenous clock function in human performance [16]. Chronotype 
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influences both physical and mental health [18, 19] with cortisol levels also being different in early 
and late hours preferring people. Early chronotype presents with a more pronounced adreno-
cortical activation after waking up compared to the late chronotype [14]. Disruption in cortisol and 
melatonin rhythms [20] are known to impair circadian rhythms and play roles in disorders 
associated with sleep [21, 22], impaired glucose tolerance, or low level of alertness [23]. 
Polymorphisms and mutations of circadian genes were identified and reported with evidence 
highlighting the transcription of circadian clock genes being epigenetically regulated by the 
changes in DNA methylation, histone modifications, and structural chromatin alterations [24]. 
Most of the epigenetic modifications are driven by the external environment and lifestyle. Lack of 
sleep and sleep disturbances are common around the globe [25, 26]. For example, at least 7 h of 
sleep per night is recommended for adults, but the data reports that more than 30% of adults in 
the United States have an insufficient sleep [27]. In Finland, a similar trend was reported with one-
third of the adult population experiencing sleep difficulties [28], where 25% reported a sleep of 6 
h or less per night [26, 28] and up to 45.3% were affected by insomnia symptoms, according to a 
previous study [28]. Shift work, for example, night shift and an early morning shift, is a common 
reason for insufficient sleep. Working in shift leads to misalignment in circadian rhythms, 
homeostasis imbalance, and shortened sleep time by 1 to 4 h [29]. Indeed, shift work disorder 
(SWD) [30] is a medical condition characterized by complaints of excessive sleepiness or insomnia, 
accompanied by a reduction in sleep duration with over one-third of shift workers suffering from 
this condition [31, 32]. Epidemiological evidence shows that disrupted sleep contributes to several 
health issues [33], specifically in the aging societies, including type 2 diabetes [34], cardiovascular 
diseases, neurodegeneration, depression, cognitive, and emotional dysfunction [35]. Sleep 
disruption can either be a single acute disruption, repeated disruptions, or even a lifetime 
disruption [36]. Therefore, sleep must be looked upon as an important state that has a 
multifaceted influence on health and well-being [37] and all aspects of sleep must be taken into 
account such as duration, timing, pattern, and quality because they can affect cellular structure, 
gene expression, metabolic and hormone regulation, mood, alertness, and quality and longevity of 
life. Over the last decade, attempts have been made for a better understanding of underlying 
mechanisms that determine the consequences of sleep disruption and experimental studies are 
conducted in both laboratory animals and humans to address the unanswered questions in the 
field. The study designs are now modified to include different modalities, describing the 
consequences and mechanisms of sleep loss under the chronic sleep disruption, which mirrors the 
current condition of many modern societies. Models for continuous, intermittent, or stage-
dependent sleep deprivation are applied for partial or total sleep deprivation (TSD) in animals and 
humans [37-39]. Advancing technologies have now permitted the identification of mechanisms 
underlying sleep disturbances and its multidimensional consequences such as the effect on brain 
cells, circuits, and metabolism shifts. However, several areas are still open for investigation, such 
as the activation mechanism of compensation or rescue and also questions about whether and 
how the adaptation occurs and failing of some processes in this regard [37].  
The growing literature shows that insufficient sleep promotes epigenetic modifications and 
both acute and chronic sleep deprivation produces broad changes in epigenetic markers and 
patterns of gene transcription in animals [40-43] and humans [44, 45]. Targeting epigenetic factors 
have been challenging for many health conditions, such as cancer, psychiatric disorders, and 
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neurodegenerative diseases. Therefore, these strategies could ultimately result in future 
interventions to prevent or treat sleep disruptions. 
2. Epigenetics of Sleep  
The term “epigenetic” means “in addition to changes in genetics” and this includes any process 
that alters gene activity without changing the DNA sequence. Epigenetic theory mainly focuses on 
the interaction between the environment and gene expression. Epigenetic markers such as 
genomic imprinting, DNA methylation, histone modifications, and non-coding RNAs were 
identified in several human health conditions and related disorders [46-49]. Although epigenetic 
modifications can be transmitted from parents to their offspring [50, 51], maintaining itself 
through the generations [52, 53], some changes do reverse. DNA methylation and histone 
modification [54] make direct structural modifications influencing the gene expression. In 
contrast, non-coding RNAs are transcribed from DNA but not translated into protein. These 
functional RNA molecules regulate gene expression at the transcriptional and post-transcriptional 
levels [54]. miRNAs are emerging as diagnostic biomarkers in many human disorders, such as sleep 
apnea [55], neurodegenerative disorders [56], and pain [57-59]. 
DNA methylation is studied extensively in cancer [60] with first reports [61] highlighting the 
alterations of DNA methylation occurring throughout the genome of various cancer tissues 
compared to the normal tissues. The majority of these cancer-linked alterations were 
demonstrated by hypomethylation [62], but gradually it became evident that hypermethylation 
[63] also occurred in many cancers. Biological significance and clinical relevance of DNA 
methylation are increasingly being notified in cancer [64] and conditions such as aging [65] or 
even other disorders, namely, neurodegenerative and cerebrovascular disorders [66]. 
Besides DNA methylation [67], chromatin, a complex of histones, proteins, and DNA tightly 
bundled into the nucleus, can also be modified [68] by acetylation, enzymes, and some forms of 
RNA, such as microRNAs and small interfering RNAs [69]. After the modification, chromatin 
structure is altered, influencing the gene expression [70].  
Another form of epigenetic inheritance is genomic imprinting, which is known in mammals, 
plants, and insects [71] and is defined as the regulation of a gene or chromosomal region 
depending on the sex of the transmitting parent [71]. The imprinted genes in the mammals are 
expressed in the parent-of-origin in a specific manner, playing an important role in the embryonic 
and extraembryonic growth and development and some human diseases, such as Beckwith-
Wiedemann syndrome (BWS) and Russell-Silver syndrome (RSS) [72].  
In the generation and regulation of the sleep-wake cycle, a complex interaction exists between 
neuroanatomical, neurochemical, neurophysiological, and genetic endogenous elements [73]. It is 
known that the environment plays a major role in the life of mammals and determines their 
developmental, physiological, or behavioral changes. It was proposed that external factors (e.g., 
light, darkness, diet, noise, heat, cold [74]), through the epigenetic mechanisms, might also 
contribute to circadian controlling of sleep and potentially be linked to sleep disturbances or 
disorders [75, 76].  
Since the epigenetic mechanisms underlying the circadian regulation and sleep disorders is a 
broad-spectrum topic falling beyond the purpose of this review, we have mainly presented the 
epigenetic mechanisms underlying sleep disruption. We refer the readers to delve into excellent 
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reviews available in the literature if interested in genetics and epigenetics of circadian regulation 
and sleep disorders, such as sleep apnea [77-80].  
2.1 Examples of Epigenetic Alterations in Sleep Deprivation 
We still have a limited understanding of epigenetic factors, onset, and underlying mechanisms 
in sleep-wake disturbances, sleep disorders, and associated chronobiological disturbances [13]. It 
is proposed that epigenetics and sleep are interrelated, but we still do not know if connections are 
causal, modulatory, or correlative [81]. Hence, several hypotheses have emerged [13], where 
epigenetic pathways directly cause sleep-wake disorders by deregulating the circadian clock. 
Insomnia and excessive sleepiness are the most common sleep disturbances [82, 83], with 
literature indicating epigenetics to be related to these conditions [45, 84]. DNA methylation, 
histone modifications, and chromatin remodeling are regulated by the circadian clock [13, 85]. A 
review article [86] has also presented the epigenetic markers of sleep deprivation from the 
findings of animal and human studies. 
2.1.1 DNA methylation 
The addition of a methyl group to a cytosine-guanine dinucleotide (CpG) is termed as DNA 
methylation and is one of the epigenetic modifications. Many studies have provided evidence that 
DNA methylation is affected by sleep [13, 42, 86-88]. Massart et al. [42] demonstrated that acute 
sleep deprivation in mice resulted in a remarkable expression of Dnmt3a1 and Dnmt3a2 genes. 
Narwade et al. [41] analyzed the transcriptome and reported altered expression of memory and 
neurotransmission associated genes in rats deprived of REM sleep. Another study has shown that 
twins with different diurnal preferences presented different DNA methylation patterns [84]. DNA 
methylation patterns are also found to be different in 52 genes in individuals who sleep less than 
6.8 h (short sleepers) compared to those who sleep more than 7.8 h (long sleepers) [89]. In 2011, 
Zhu et al. [90] reported hypermethylation of cryptochrome circadian clock 2 (CRY2) and 
hypomethylation of CLOCK in the long-term night-shift workers. Four years later, Cedernaes et al. 
[88] reported the occurrence of DNA methylation following one night of sleep deprivation in men. 
The results from this study showed that CpG sites in period circadian clock 1 (PER1) and CRY1 
promoter were significantly hypermethylated in adipose tissue samples obtained from sleep-
deprived men. However, no difference was found in gene expression, proposing a potential gap 
time following the DNA methylation, which can be explained by the potential requirement for 
more changes. For example, the contribution of several CpG sites or other mechanisms such as 
histone modifications or contribution of non-coding RNAs [88]. Nilsson et al., in 2016 [45] 
performed a genome-wide DNA methylation study and found that 269 probes were significantly 
altered in blood samples of sleep-deprived healthy men and to identify the potential genes with 
altered expression and DNA methylation changes following the sleep deprivation, the authors of 
this study correlated their results with Möller-Levet et al. [91]. The correlation showed that one 
CpG site with decreased DNA methylation in the Inhibitor of growth 5 (ING5) gene correlated to a 
similar decrease in expression of ING5 [45].  
These studies demonstrate that changes in DNA methylation occur in response to sleep 
deprivation and can help identify the epigenetic pathways affected by sleep loss. Further 
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investigations are required to define the patterns of sleep-specific DNA methylation and its 
consequences [86]. 
2.1.2 Histone Modification 
Histones can be modified [92] by methylation on lysine or arginine residue, but the methylation 
is mostly observed in histone tails H3 and H4 at lysine residue. Histone methylation can be 
associated with either transcriptional repression or activation, depending on the position of the 
residues modified and the number of methyl groups. Histone methylation is mediated by 
chromatin remodelers, including histone methyltransferases, histone lysine demethylases (KDMs), 
and other histone-modifying enzymes. Histone methylation and demethylation play an important 
modulatory role in the chromatin restructuring and RNA transcription, hence, controlling a diverse 
range of biological processes [92]. For example, studies have suggested that compounds such as 3-
deazaneplanocin A (DZNep) inhibit histone trimethylation of lysine 27 on histone H3 and lysine 20 
on histone H4. DZNep is shown to control the sleep-wake cycle and release sleep-related 
neurochemicals via the histone methylation process [93]. 
Histone can also be acetylated by the enzyme histone acetyl-transferase (HAT), while 
deacetylation reactions are handled by histone deacetylase (HDAC). Histone acetylation reduces 
the interaction between histone and DNA, leading to the loosened chromatin conformation, which 
further facilitates transcriptional events. Histone acetylation is required in the regulatory process 
of gene expression, and it is shown that maintenance of circadian rhythm and sleep homeostasis is 
modulated by circadian genes, where the gene expression is regulated by histone modifications.  
Disrupted sleep homeostasis was reported in the mice models lacking in circadian genes [94], and 
since sleep deprivation alters the circadian gene expression, histone modification can be one of 
the potential underlying mechanisms. However, only a few studies have looked into histone 
acetylation after the occurrence of sleep deprivation. Duan et al. [40] analyzed the samples of the 
hippocampus from sleep-deprived rats and identified reduced acetylated histones at BDNF 
promoter IV. This observation was consistent with a previous study by Guzman-Marin et al. [95], 
who showed a reduced BDNF transcription and translation following prolonged sleep deprivation 
state. Future studies are required to identify the epigenetic markers present on the chromatin 
that are altered by sleep loss [86], eventually leading to the identification of sleep-specific 
biomarkers and targeting sleep loss disorders. 
2.1.3 Non-Coding RNAs  
As their name suggests, non-coding RNAs are the molecules that are transcribed from DNA but 
do not code for proteins. Several types of non-coding RNAs exist that are classified into two large 
groups based on their size: long non-coding RNAs (lncRNAs) and microRNAs. In recent years, a 
growing number of publications are available on the potential role of these molecules in health 
and disease [96, 97].  
LncRNAs are >200 base-pairs, which can modify the structure of chromatin in the nucleus and 
alter gene expression [98]. It is identified that certain lncRNAs encode micro peptides that are 
found in the brain [99], opposing the commonly accepted term of being non-coding. LncRNAs are 
also associated with the circadian genes. For example, the ablation of lncRNA 116HG [100] causes 
dysregulation of CLOCK, Cry1, and Per2. In 2016, Davis et al. [101] reported differential expression 
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of several lncRNAs following sleep deprivation. Although the roles of lncRNAs in the diseases of 
the central nervous system are being clarified increasingly [102], there is no explanation regarding 
the associated function of these lncRNAs affected by sleep deprivation [86].  
MicroRNAs are small molecules of ~22 nucleotides and are abundant in the brain, where they 
associate with neurological processes such as synaptic plasticity [103, 104]. MicroRNAs are also 
associated with sleep deprivation with mir-132 [105] and miR-138 [106] being found in sleep-
deprived rats. A genome-wide study by Davis et al. [107] reported significant alterations in let-7b 
and miR-125a in the brain following sleep deprivation. Table 1 presents examples of altered non-
coding RNAs that follow sleep deprivation.  
To identify the non-coding RNAs in the epigenetic mechanisms underlying the sleep disruption 
in future studies, it is suggested to perform the RNA-sequencing analyses along with the validation 
by cloning [86]. 
Table 1 Examples of altered non-coding RNAs following sleep deprivation. 
Study Outcome Reference 
Sleep deprivation in mice 
(Male homozygous P2X7RKO 
mice, and wild type mice)  
 
In wild type mice, sleep deprivation 
increased hypothalamic 
4930470G03Rik, A230107N01Rik, 
C130021I20Rik, Gm17354, and 
decreased A430010J10Rik 
expression 
 
In P2X7RKO mice, sleep deprivation 
increased only 6820431F20 levels  
 
2 potential lncRNA targets related to 
sleep were identified: 
9430037G07Rik and Gm15832  
Davis et al., 2016 
[101] 
Sleep deprivation in rats (Male 
Sprague-Dawley rats) 
let-7b, miR-138, miR-125a are 
involved in sleep regulation 
 
miRNAs expression differs based on 
time of the day (end of dark 
compared with the end of light), let-
7b, miR-138, miR-125a higher levels 
were found in pre-light onset. 
 
miRNAs expression differs based on 
brain region (the highest 
concentrations in the hippocampus, 
moderate in the hypothalamus, and 
prefrontal cortex, and lower in the 
occipital and somatosensory 
Davis et al., 2012 
[106]  
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cortices) 
 
Sleep deprivation in rats (Male 
Sprague-Dawley rats) 
miRNA-132 is involved in sleep 
regulation 
 
Spontaneous brain levels of miRNA-
132 depend on brain site 
(hippocampus, prefrontal cortex, 
somatosensory cortex, and 
hypothalamus) and time of day 
 
miRNA-132 was highest at the 
prefrontal cortex and at dawn 
Davis et al., 2011 
[105] 
Patients with major depression 
affected by late insomnia (359 
major depression patients and 
341 controls) 
 
miR-182 is involved in insomnia 
 
miR-182 inhibits Adenylate Cyclase 6 
(ADCY6), CLOCK, and DSIP 
expression;  
the abnormal processing of pre-miR-
182 in patients carrying the T allele 
of the rs76481776 polymorphism 
may contribute to the dysregulation 
of circadian rhythms in these 
patients with insomnia 
Saus et al., 2010 
[108] 
Sleep deprivation in mice (Male 
mice 57BL/6J, AKR/J, and DBA/2J) 
10 miRNAs expression altered with 
sleep deprivation; upregulated (miR-
410, −212, −29c, −29b-2, and −708) 
and  downregulated (let-7e, miR-
137, −22, −219–2, and −99a) 
 
miR-410, −212, −29c, and −151 were 
verified; potential targets were 
found for miR-151 and a tendency 
for miR-212  
Mongrain et al., 
2010 [109] 
Sleep deprivation in rats (Male 
Sprague Dawley rats) Genome-
wide study 
50 miRNAs were affected by sleep 
loss.  
Let-7b and miR-125a significantly 
changed in all four brain regions 
 
The number of miRNAs and their 
expression affected by the sleep loss 
were brain region dependent.  In 
hippocampus, miRNA expression 
Davis et al., 2007 
[107] 
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increased but in somatosensory and 
prefrontal cortices decreased. In the 
hypothalamus miRNAs were both 
up- and down-regulated. 
2.2 Examples of the Consequences of Epigenetic Regulations in Sleep Disruption   
2.2.1 Epigenetics of Sleep Disturbances and Metabolic Consequences 
Chronic loss of sleep, social jet lag, and shift work are the most common reasons that are linked 
to an elevated risk of metabolic disorders, such as type 2 diabetes, metabolic syndrome, and 
obesity [110-113]. A shift in the sleep time because of weekly environmental changes or a 
continuous five nights of short sleep is reported to elevate the risk of weight gain in healthy 
individuals [113, 114]. Metabolic perturbations follow a tissue-specific pattern in peripheral 
tissues such as skeletal muscle and adipose tissue [115, 116]. It is also proposed that sleep loss can 
promote adverse catabolism and anabolism in a tissue-specific manner [117], e.g., loss of muscle 
mass [118, 119]. However, the underlying molecular mechanisms are less investigated. A single 
night of sleep loss in humans was shown to induce tissue-specific transcriptional and DNA 
methylation changes in circadian clock genes [88], although the downstream tissue-specific impact 
on metabolic pathways was not determined.  
 In 2018 [87], the effects of acute sleep loss were investigated on tissue-specific alterations in 
the metabolic pathways, i.e., anabolic versus the catabolic state. This study hypothesized that 
acute sleep loss would promote adipogenesis, reflecting changes in DNA methylation. Samples 
from subcutaneous adipose tissue and skeletal muscle were obtained from healthy young men, 
following a night of sleep loss and a night of full sleep, for subsequent analysis [87]. This study 
showed the glycolytic pathway being down-regulated in skeletal muscle but upregulated in 
subcutaneous adipose tissue. Transcriptomic markers of inflammation were found in both tissues, 
and this was the first human evidence to demonstrate that acute sleep loss may re-program DNA 
methylation in adipose tissue, promoting adipogenesis in adipose tissue and catabolism in skeletal 
muscles [87]. These observations partially explain the underlying mechanisms of weight gain and 
sarcopenia following the disturbance in sleep and circadian rhythm [87]. These findings were 
consistent with the animal studies (rats) deprived of extended REM sleep, which demonstrated 
atrophy in only glycolytic and mixed muscles but not in oxidative muscles [119, 120]. Insufficient 
sleep in middle-aged and older adults is found to be associated with lower skeletal muscle mass 
[111, 118]. With the presence of catabolic markers in blood and urine, loss of sleep is also 
observed [116, 121]. Higher catabolism following an acute sleep loss might be due to the 
regulatory hormonal disruptions. Cortisol, a catabolic hormone, is elevated following an acute 
sleep loss while testosterone [122] and nocturnal growth hormones [123] are lowered.  
Changes in DNA methylation were observed in the genes that were previously demonstrated in 
adipose tissue of obese and type 2 diabetic patients, just after losing one night’s sleep. It remains 
to be elucidated whether other environmental factors such as diet, exercise, and stress could 
modulate or alter the duration of these changes towards a worsened or rather a protective state 
or not [87]. A recovery sleep during the weekends, however, failed to prevent metabolic 
dysregulation, according to a 2019 study [124]. In this study, Depner et al. [124] evaluated sleep, 
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circadian timing, energy intake, weight gain, and insulin sensitivity during a period of 9 
consecutive nights of insufficient sleep, followed by a weekend of ad libitum recovery sleep. 
Young, healthy individuals were divided into three groups: control, insufficient sleep without 
weekend recovery sleep, and insufficient sleep with weekend recovery sleep groups. The results 
presented that insufficient sleep delayed the circadian phase and increased the energy intake 
along with the body weight compared to the baseline. Weekend recovery sleep was not sufficient 
or effective in reversing the metabolic alterations caused by recurrent insufficient sleep. Also, a 
gender-related response was observed during the weekend recovery phase, where women 
showed lowered total sleep duration and a decreased energy intake of baseline levels when 
compared to men. This highlights the importance of including both females and males in sleep-
related studies associated with epigenetic factors. In addition, this study provided evidence that 
the general belief of weekend recovery sleep reversing the sleep-loss alterations might not be true 
in normalizing the metabolic dysregulation caused by recurrent insufficient sleep [124].  
Pregnancy is known as a condition in which lifestyle is transiently affected. There are numerous 
recommendations and guidelines available for parents to maintain maternal mental and physical 
health with various choices of activities, including diet, exercise, and sleep [125-128]. A majority of 
pregnant women experience sleep disorders, including fragmented or inadequate sleep [127, 
128]. Sleep fragmentation is reported, especially during the late gestation phase [129], and sleep 
disorders in pregnancy were also associated with increased gestational weight gain, pregnancy 
complications such as gestational diabetes mellitus, and adverse perinatal and post-natal 
outcomes. For example, intrauterine growth restriction, low birth weight, preterm birth, a child’s 
risk of overweight and obesity [130-132] are proposed to occur in offspring through epigenetic 
modifications [133]. Although some mice studies have provided evidence for the role of epigenetic 
factors and mediating pathways during pregnancy, there is still a lack in human studies that link 
gestational sleep disruption with the cardio-metabolic health of the offspring. A 2015 study 
demonstrated that sex dimorphism existed in mice offspring following the late gestational sleep 
fragmentation [134]. In this study, only the male offspring had higher food intake, body weight, 
visceral fat mass, insulin resistance, and lower adiponectin levels. Dyslipidemia was, however, 
apparent in both sexes [134]. Another study by this group investigated the effects of sleep 
fragmentation during late gestation on the metabolic function and expression of adiponectin in 
visceral white adipose tissue of the mice offspring. Male offspring of mice in the sleep fragmented 
group was assessed, and an increase was observed in their food intake, body weight, visceral 
white adipose tissue mass, and insulin resistance while adiponectin expression was reduced in the 
visceral white adipose tissue. Several epigenetic markers were also identified on the adiponectin 
found in visceral white adipose tissue of adipocytes in a male mouse offspring along with a 
metabolic syndrome-like phenotype. This study highlighted the importance of an altered 
gestational environment that can cause long-lasting metabolic consequences for future 
generations [135]. Later in 2016, two other mice studies [136, 137] demonstrated that gestational 
sleep deprivation could elevate blood pressure in offspring through the autonomic regulation in 
cardiovascular and renal alterations [23, 24]. A recent study in humans has evaluated the 
association between gestational sleep deprivation, childhood adiposity, and cardio-metabolic 
health [130]. Data from two European cohorts were used to accommodate diversity in ethnic and 
demographic characteristics, and it was found that gestational sleep deprivation might be 
associated with an increased risk of overweight and higher blood pressure in offspring till the age 
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of 11  years [130]. This study also showed that the association was more pronounced in girls than 
boys [130], which is in contrast with mice study. Along with sleep deprivation, the authors of this 
study also encourage further studies on sleep quality during pregnancy [130]. Also, there is a need 
for an official sleep recommendation for pregnant women; however, based on the findings of this 
study, sleep deprivation (i.e., sleep duration of 6 h and less) has to be avoided at any stage of 
pregnancy [130]. 
2.2.2 Sleep Deprivation Alters Brain and Blood Phenome 
Analysis of both animal and selected human samples have provided evidence that sleep 
deprivation alters the transcriptome and methylome [42, 43, 88, 138-140]. In rats, sleep 
deprivation altered the brain transcriptome affecting protein synthesis, synaptic plasticity, and 
metabolism [138, 141]. Archer et al. [142] presented that mistiming sleep could reduce rhythmic 
transcripts and cause remarkable alterations in the transcriptome. The average methylation in the 
night-shift workers was significantly reduced compared to the dayshift workers [143, 144]. This 
implies that underlying mechanisms with negative consequences of chronic lack of sleep need 
greater attention towards the night-shift workers. Genetic risk factors are also reported in people 
having an intolerance towards shift work [145] and an association was found between job-related 
exhaustion and a variant of the melatonin receptor 1A gene, proposing that the mechanism of 
changes in DNA methylation at the gene promoter are in response to the shift work [145]. In light 
of the value of studying DNA methylation for understanding mechanisms underlying insomnia, in 
2019, Lahtinen et al. [146] investigated blood leukocytes to identify differentially methylated DNA 
in samples obtained from DILGOM, a sub-study of the population-based FINRISK along with a 
population that consisted of airline shift workers. This cross-sectional, genome-wide study 
identified a remarkable low level of DNA methylation (hypomethylation) in both cohorts 
associated with sleep loss [146]. A distinctive pattern was observed in individuals having sleep 
disturbances, where 399 differentially methylated positions were identified, out of which 327 
were linked to the nervous system development pathway, which is also in line with the previous 
data, where DNA methylation induced by sleep disturbances was involved in synaptic plasticity 
and neuritogenesis [42]. It is worth mentioning that previous studies have analyzed DNA 
methylation in the brain tissue of rodents, whereas Lahtinen et al. [146] revealed these systemic 
changes in response to sleep disturbances in human blood samples. This shows that it is important 
to consider systemic sleep disturbance effects while selecting the right choice of sample for 
analysis.  
Future studies must consider racial and ethnic disparities while designing epigenetic studies 
regarding sleep and sleep disruptions. An association analysis study consisting of a racially diverse 
population [147] measured DNA methylation in monocytes to identify whether a link exists 
between these markers and daytime sleepiness, and it was found that most significant DNA 
methylation was specific to African Americans [147].   
2.2.3 Irregular or Shorter Sleep Accelerates Epigenetic Aging 
A recent pilot study by Carskadon et al. [148] in young females identified that shorter or 
irregular sleep might advance epigenetic aging. In this study, 12 young women, defined as short or 
long sleepers, were studied for nine weeks. Blood samples were obtained to determine the effects 
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of DNA methylation levels on epigenetic age. The results revealed that longer and regularly 
sleeping females had a lesser difference between their chronological and epigenetic age 
compared to those with shorter and irregular sleep. Thus, poor sleep was found to be associated 
with a marked acceleration of epigenetic aging [148]. Regular meditation has been suggested to 
slow down the epigenetic aging [149]. Also, exercise reduces DNA methylation at age-related CpG 
sites [150, 151], highlighting the value of studies on behavioral interventions in epigenetic 
mechanisms. This is particularly an interesting area since a review from 2018 [152] had discussed 
the potentials of epigenetic regulation of the adult dentate gyrus (DG) neurogenesis and the 
influence of sleep and epigenetic modifications on this neurogenesis. Evidence shows that 
cognitive and emotional processing and memory consolidation are affected by the neurogenesis, 
thereby suggesting ways to use sleep or epigenetic interventions as therapies for 
neurodegenerative and psychiatric disorders [152]. In light of the growing population of aged 
people and the prevalence of neurodegenerative and neuropsychiatric disorders in our societies, 
studying sleep-related neural processes and epigenetic mechanisms may facilitate novel 
approaches to prevent and treat these disorders.  
2.2.4 Role of Epigenetic Regulations in Sleep under the Influence of Other Lifestyle Factors  
Sleep is influenced by several other lifestyle factors [153], including diet, exercise, smoking, and 
medications. Further research is needed to understand the mechanisms underlying the effects of 
all these factors. The effects of diet are more commonly studied among these factors. High 
carbohydrate diets, along with the foods containing tryptophan, melatonin, and phytonutrients 
(e.g., cherries) were linked to improving sleep outcomes [154]. This effect is proposed to be 
exerted through serotonin and melatonin. Also, it is reported that after short-term sleep 
deprivation, melatonin can promote the proliferation of neural stem cells in the adult 
hippocampus, where evidence indicates that epigenetic regulators may be involved. A recent 
study [155] investigated the effect of melatonin treatment on a 96-hour sleep-deprived subject 
and analyzed the expression of epigenetic modulators.  The results showed that the 
administration of melatonin under sleep-deprived conditions increased MECP2 expression but 
reduced SIRT1 expression in DG. Let-7b, mir-132, and mir-124 were highly expressed upon the 
administration of melatonin but were not modified by sleep deprivation. In the subgranular zone 
of the sleep-deprived group treated with melatonin, more number of Sox2+/5-Bromo-2′-
deoxyuridine (BrdU)+ cells were identified compared to the untreated group. These findings may 
support the notion that melatonin modifies the expression of epigenetic mediators, which in turn 
regulates the proliferation of neural progenitor cells in the adult DG under long-term sleep-
deprived conditions. However, sleep-melatonin and its interaction with epigenetic factors need 
further investigation.  
Coffee is a commonly consumed drink and is widely discussed for its related risks and benefits 
in health [156]. For example, heavy consumption of coffee can induce insomnia [156], and caffeine 
is known to reverse the negative effects of sleep deprivation while promoting prolonged 
wakefulness [157, 158]. Caffeine blocks adenosine from binding to its receptor, resulting in 
improved cognitive function and increased alertness [159, 160]. DNA methylation is proposed to 
play a role in caffeine-health interaction [161]. Epigenetic studies of caffeine were mainly reported 
in animals [162-164], while the first study in humans was conducted by Chuang et al. in 2017 [165] 
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to investigate whether coffee consumption induced epigenetic changes in humans. The results of 
this study suggested that coffee affected DNA methylation levels in blood immune cells [165]. 
Many of the differentially methylated CpGs related to coffee consumption were located in or near 
the genes that were associated with coffee-related chronic diseases, including the 
neurodegenerative diseases (e.g., Parkinson’s Disease and Alzheimer disease). Interestingly, coffee 
is also known to be beneficial for these neurodegenerative disorders [166, 167]. However, one 
must consider that the study by Chuang et al. [165] included mixed race and gender and did not 
particularly focus on sleep. Therefore, the effects of caffeine on epigenetic modifications of sleep 
would need further investigation. 
Other dietary components were also proposed to alter epigenetic pathways that might have 
potentially interacted with sleep. For example, dietary methyl donors (e.g., folate and choline) 
were proposed to promote DNA methylation and, in turn, increased promoter methylation was 
associated with transcriptional suppression [168]. Based on this, “epigenetic diets”, were also 
proposed [169], but these diets were questionable since the term epigenetic diet was used for the 
diet, which was folate-rich as well [170].  
Dietary components were also proposed to influence histone modification [171]. Gut-brain axis 
and bidirectional cross-talk were being investigated extensively in many human health conditions 
[153]. A diverse range of methods was applied to modulate the gut microbiome, including 
antibiotic therapy, fecal microbiota transplant, or dietary intervention, such as the use of 
probiotics [172]. Probiotics have shown promising results in many conditions, such as 
neurodegenerative disorders [173] and migraine [174]. Dietary factors can modify the gut 
microbiome through epigenetic pathways [175], and this might be applicable to sleep disorders as 
well.  
Omic studies can be employed to investigate transcriptomics, proteomics, and metabolomics of 
sleep-diet interactions. Changes in the DNA methylation patterns, histone modifications, and 
regulatory RNA transcriptomics would broaden the spectrum to characterize and understand the 
complicated interaction between sleep and other lifestyle factors such as diet, in light of 
epigenetics, and this will eventually lead to a personalized medicine strategy [176]. However, this 
is challenging because multiple lifestyle factors are concurrently being tested. Epigenetics is also 
involved in a wide range of processes and can facilitate better adaptation to environmental factors 
and is not always associated with a negative outcome. Therefore, understanding how to modulate 
the epigenetic-related factors optimally may prove beneficial in coping and adaptative methods. 
3. Future Perspectives  
Studying epigenetic mechanisms of sleep disruption and its reversal is a fascinating and 
growing field, yet it is complicated and challenging to deal with. Although few studies have 
elucidated the roles and the epigenetic mechanisms of sleep disruption to some extent, our 
review positively provides the evidence for these as well. Further investigation of functional 
interactions between epigenetic factors and sleep disorders would help in understanding the 
nature of the interaction. It is desirable to understand if the interactions are causal, modulatory, 
or correlative. Along with the identification of epigenetic factors influencing sleep, we also need to 
consider investigations that focus on recovery or prevention of these alterations to restore the 
balance or normalize sleep disturbances. We need evidence provided by further research in a 
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diverse range of models with different conditions related to the neurobiology of sleep, to identify 
whether epigenetic mechanisms, such as DNA methylation, are disturbed in such cases and if 
blocking the DNA methylation can reverse the condition. Interventions might range from simple 
modification strategies such as recovery sleep, diet, exercise to multidimensional or integrated 
strategies that include medications, coping, and adaptation strategies. However, one must also 
consider counterbalance risk and safety issues of modification strategies. Most experimental 
studies in humans and animals focus on acute controlled conditions, which are highly valuable, but 
chronic sleep alterations and reversal strategies may show a different pattern on the epigenome. 
Also, most studies focus on sleep loss, whereas sleepiness studies are equally important. 
Interestingly, some small changes in sleep may lead to unexpected epigenetic alterations, which 
are important to consider in study designs. For example, changes in the length of the day may 
influence the pattern of DNA methylation. Azzi et al. [177] kept mice under a day length of 22-
hour and 24-hour, and this small change of 2-hour difference revealed alterations in methylation 
patterns at promoter regions of SCN, leading to changes in gene expression. This supports the idea 
that DNA methylation might be a sensitive and rapidly occurring process. These alterations were, 
however, reversed when a cycle of 24-hour was extended over two weeks in this study [177], 
highlighting that DNA methylation might serve as an adaptive process that can be adjusted to 
environmental conditions, such as altered day length. Therefore, it can be assumed that DNA 
methylation might be beneficial in body coping strategies. This is an interesting finding as people 
living far north may show different patterns of DNA methylation at baseline levels and also be 
differentially affected in response to circadian changes.  
Epigenetics can also be explored to help in the diagnosis or stratification of patients, where the 
expression of epigenetic markers in insomnia or sleepiness could be used as diagnostic criteria. 
These markers can also help with the optimal choice of pharmacological or non-pharmacological 
interventions [80]. If further evidence confirms a relationship between epigenetic changes and 
sleep disorders, then stimulation or inhibition of epigenetic markers may offer a novel strategy for 
the treatment or prevention of sleep disorders, which is valuable because current strategies 
applied in sleep disturbances [178-180] are only partially effective or carry side effects. Also, sleep 
disturbances are often comorbid, and this complexity makes therapeutic management even more 
challenging [80].  
Omics have proved useful in studying many health-related conditions, such as cancer, 
metabolic disorders, or pain [181-183]. Integrative omic systems (genomics, proteomics, or 
metabolomics) would be beneficial in studying epigenetic mechanisms underlying sleep 
disruption, as it allows us to study the expression of markers at different interactive levels. In 
order to analyze the consequences of environmental influence [184], potential sleep-disturbing 
factors, such as high work demands, light exposure, job strain, noise, and shift schedules can be 
considered [185-187]. Isolated and integrated lifestyle factors related to epigenetics can bring new 
insight into interacting factors (such as diet, exercise, smoking, and stress) since they are 
unavoidable in real-life conditions. 
Animal models have provided useful information on molecular mechanisms of sleep disorders, 
including narcolepsy, sleep apnea, restless legs syndrome, and insomnia [39]. DNA methylation, 
histone modifications, chromatin remodeling, non-coding RNA regulation, and RNA editing can be 
studied in these models [188, 189]. However, the translatability of this data to humans must be 
considered carefully with factors such as race, sex, comorbid disorders, and concomitant 
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medications, which can lead to proper designing of future studies. Hence, multimodal assessment 
and correlation analysis of objective and subjective markers related to sleep can enrich our 
understanding of underlying mechanisms and complexity of targeting. Also, different epigenetic 
elements must be considered to design future studies.  
 Considering the limited but promising findings and several open research avenues in this field, 
it is highly expected to witness rapidly emerging studies and evidence generation in the coming 
years on the role and significance of epigenetic regulation in sleep disruptions. Epigenetic studies 
for sleep disorders will not only enhance our understanding of the risks but also help in 
recognizing the importance of various environmental factors influencing the sleep disorders, and 
eventually modulating these factors may further help us in treating patients and providing 
preventive strategies.  
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